Trademarkia Logo

Australia

AU$
DAXIENCE
Withdrawn: Applicant request

Last updated on 15 Feb 2020

Owner Info

Revance Therapeutics, Inc. a Delaware Corporation

7555 Gateway Boulevard

Newark, California, 94560 UNITED STATES OF AMERICA,

Serial Number

2069034 filed on 13 Feb 2020

Correspondent

Maxwells Patent & Trade Mark Attorneys Pty Ltd

PO Box R1466,

Royal Exchange,

SYDNEY, NSW, 1225 AUSTRALIA

DAXIENCE

Classification Information


Class [005]
pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headach Read More

Mark Details


Serial Number

2069034

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

15 Aug 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
15th Feb 2020IP Right Withdrawn correspondence sent
14th Feb 2020General Notice Published
14th Feb 2020Status change to Withdrawn
14th Feb 2020Awaiting examination
14th Feb 2020Examination expedited
14th Feb 2020IP Right Filed correspondence sent
14th Feb 2020Withdrawal of IP Right Requested
13th Feb 2020IP Right Filed Published
13th Feb 2020Status change to Published
13th Feb 2020Status change to Filed